Eli Lilly’s $8 billion acquisition of Loxo Oncology looks like it could pay off, with new data for RET inhibitor selpercatinib setting up a filing before the end of the year. The results of the ...

Bayer has acquired full rights to two drugs partnered with Loxo Oncology, on the same day that the biotech was taken over by Eli Lilly in an $8 billion deal. Bayer first partnered with Loxo on the ...

AUSTIN, Texas, Feb. 20, 2025 /PRNewswire/ -- Loxo, a talent intelligence platform and recruiting software company, today announced its closing of a growth investment led by Tritium Partners ...